Common Side Effects in Pediatric Patients
Methotrexate, used for conditions like juvenile idiopathic arthritis (JIA) or leukemia in children, often causes nausea, vomiting, and mouth sores (stomatitis). These gastrointestinal issues affect up to 70% of kids on weekly low-dose therapy and typically improve with dose adjustments or anti-nausea drugs like ondansetron.[1][2]
Fatigue, headache, and hair thinning also occur frequently, resolving as the body adjusts. Folic acid supplementation reduces many of these effects without lowering efficacy.[3]
Serious Risks and Long-Term Concerns
High-dose methotrexate, common in cancer treatment, risks acute kidney toxicity, requiring hydration and leucovorin rescue to prevent organ damage. Liver enzyme elevations happen in 10-20% of children, sometimes leading to fibrosis with prolonged use—regular blood tests monitor this.[1][4]
Bone marrow suppression can cause low blood counts, increasing infection or bleeding risk; this is dose-dependent and reversible.[2]
In JIA patients, rare pneumonitis (lung inflammation) appears in under 5%, with symptoms like cough and shortness of breath needing immediate evaluation.[3]
Growth and Development Impacts
Children on long-term methotrexate may experience delayed growth or bone density loss, especially at higher doses or combined with steroids. Studies show height velocity reductions in 10-15% of JIA kids, often catching up after stopping treatment.[4][5]
Fertility concerns exist but are low with low-dose regimens; sperm counts normalize post-treatment in boys, though girls face potential ovarian risks during high-dose therapy.[1]
Monitoring and Risk Factors
Weekly blood tests check liver function, kidney status, and blood counts. Kids with obesity, diabetes, or alcohol exposure (rare in pediatrics) face higher liver risks. Genetic factors like MTHFR mutations may increase toxicity.[2][3]
Avoid live vaccines during treatment due to immunosuppression. Pregnancy is contraindicated—effective contraception is required for adolescents.[5]
[1]: American College of Rheumatology - Methotrexate for JIA
[2]: UpToDate - Methotrexate in pediatric rheumatology
[3]: Pediatric Rheumatology Journal - Adverse effects of MTX in children
[4]: FDA Label - Methotrexate
[5]: Cochrane Review - MTX for JIA